Trump’s Malaria Drug Fails Another Trial On Covid-19 Patients

Cat:

Related stories

Trump announces new tariffs of up to 40% on a growing number of countries  

President Donald Trump cranked up the pressure Monday on...

OPEC+ to Complete Unwinding of Oil Output Cuts With Big September Hike

OPEC+ plans to fully unwind its 2.2 million...

Shettima Says Nigeria Not Interested in Pursuing Nuclear Weapons

By Abiola Olawale Vice President Kashim Shettima has reiterated Nigeria’s...

[VIDEO] First Class journalist-Scholar, Reuben Abati Blasts Wike Over Church Thanksgiving on Completed Projects

By Abiola Olawale Veteran international journalist, lawyer and first class...

Iranian President Accuses Israel of Failed Assassination Plot

By Abiola Olawale Iranian President Masoud Pezeshkian has made a...

U.S. President Donald Trump’s malaria drug which he touted as a “game changer” for coronavirus has again failed to show a benefit in hospitalised patients.

A study published in the New England Journal of Medicine reported that the use of hydroxycholoquine neither lessened the need for patients requiring breathing assistance nor the risk of death.

“We didn’t see any association between getting this medicine and the chance of dying or being intubated,” lead researcher Dr. Neil Schluger told Reuters in a telephone interview.

“The patients who got the drug didn’t seem to do any better.”

Among patients given hydroxychloroquine, 32.3% ended up needing a ventilator or dying, compared with 14.9% of patients who were not given the drug.

But doctors were more likely to give hydroxychloroquine to sicker patients, so researchers at New York-Presbyterian Hospital and Columbia University Irving Medical Center adjusted the rates to account for that.

They concluded that the drug may not have hurt patients, but it clearly did not help.

Decades old hydroxychloroquine, which is also used to treat lupus and rheumatoid arthritis, also showed no benefit when combined with the antibiotic azithromycin, Schluger’s team reported.

Azithromycin alone also showed no benefit.

Last month, doctors at the U.S. Department of Veterans Affairs reported that hydroxychloroquine did not help COVID-19 patients and might pose a higher risk of death.

That analysis of medical records showed a death rate of 28% when the drug was given in addition to standard treatments, compared to 11% with standard care alone.

In the latest study, 811 patients got hydroxychloroquine and 565 did not.

Because they were not randomly assigned to receive hydroxychloroquine or a placebo, “the study should not be taken to rule out either benefit or harm” for the drug, researchers said.

Randomized trials, the gold standard for tests of new therapies, should continue, they added.

But for now, “the guidance in our hospital has changed so we don’t recommend giving hydroxychloroquine to hospitalised patients,” said Dr. Schluger, chief of the division of pulmonary, allergy and critical care medicine at Irving.

Reuters/NAN

'Dotun Akintomide
'Dotun Akintomide
'Dotun Akintomide's journalism works intersect business, environment, politics and developmental issues. Among a number of local and international publications, his work has appeared in the New York Times. He's a winner of the National Youth Service Corps (NYSC) Award. Currently, the Online Editor at The New Diplomat, Akintomide has produced reports that uniquely spoke to Nigeria's experience on Climate Change issues. When Akintomide is not writing, volunteering or working on a media project, you can find him seeing beautiful sites like the sandy beaches that bedecked the Lagos coastline.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

NDN
Latest News
Trump announces new tariffs of up to 40% on a growing number of countries  OPEC+ to Complete Unwinding of Oil Output Cuts With Big September HikeShettima Says Nigeria Not Interested in Pursuing Nuclear Weapons[VIDEO] First Class journalist-Scholar, Reuben Abati Blasts Wike Over Church Thanksgiving on Completed ProjectsIranian President Accuses Israel of Failed Assassination Plot2027: Yobe Swings as Adamu Waziri, PDP's BoT member Dumps Party for ADCSaudi Arabia Raises Oil PricesGrass Cutting! Ex-SGF Babachir Lawal Dumps APC, Heads to ADC Ahead 2027Drama in Kano, as 58 Inmates Seat for 2025 NECO SSCESword of Democles! Trump’s 10% Tariff Threat Dangles Over Nigeria, Others Over BRICS PartnershipMakinde Mourns as Olubadan’s Passes Away at 90Concerns Soars as Nigeria Unbelievably Lags Behind Libya, Gabon, Equatorial Guinea in World Bank’s 2025 Income Rankings2027: Political Intrigues Escalate as Obi Affirms Presidential Ambition, Declines VP SlotOjuri and Her One-Upper Friend: A Story About Listening, Healing, and Guarding Your PeaceRanked: The Best Countries for Work-Life Balance in 2025
X whatsapp